<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://localhost:8080/xmlui/handle/123456789/75">
    <title>DSpace Collection:</title>
    <link>http://localhost:8080/xmlui/handle/123456789/75</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://localhost:8080/xmlui/handle/123456789/1876" />
        <rdf:li rdf:resource="http://localhost:8080/xmlui/handle/123456789/1875" />
        <rdf:li rdf:resource="http://localhost:8080/xmlui/handle/123456789/1874" />
        <rdf:li rdf:resource="http://localhost:8080/xmlui/handle/123456789/1873" />
      </rdf:Seq>
    </items>
    <dc:date>2026-01-20T08:26:55Z</dc:date>
  </channel>
  <item rdf:about="http://localhost:8080/xmlui/handle/123456789/1876">
    <title>The Effect Of Rivaroxaban And Dabigatran On Glycemic Parameters And Lipid Profile In High Fat Diet And Low Dose Streptozotocin Induced Diabetes Mellitus In Male Wistar Rats</title>
    <link>http://localhost:8080/xmlui/handle/123456789/1876</link>
    <description>Title: The Effect Of Rivaroxaban And Dabigatran On Glycemic Parameters And Lipid Profile In High Fat Diet And Low Dose Streptozotocin Induced Diabetes Mellitus In Male Wistar Rats
Authors: REG.N0: BO0121004
Abstract: Introduction&#xD;
The current experimental study aimed to evaluate the effect of Rivaroxaban and Dabigatran on glycemic parameters in a High-fat diet and low dose Streptozotocin-induced Diabetes Mellitus in male Wistar rats. In addition, the effect on the Lipid profile and inflammatory markers were also assessed.</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://localhost:8080/xmlui/handle/123456789/1875">
    <title>Effect Of Cilnidipine on Depression Paradigm in Male Swiss Mice-An Experimental Study</title>
    <link>http://localhost:8080/xmlui/handle/123456789/1875</link>
    <description>Title: Effect Of Cilnidipine on Depression Paradigm in Male Swiss Mice-An Experimental Study
Authors: REG.N0: BO0121003
Abstract: Introduction&#xD;
Depression is a commonly occurring ailment that frequently coexists with cardiovascular problems, impacting approximately 16-23% of individuals. Emerging genetic, ex vivo, and clinical trial evidence suggest that Calcium channel blockers (CCB) have a positive effect on mood and cognitive performance. The hypothesis posits that calcium channel blockers (CCB) alter the release of central neurotransmitters, particularly noradrenaline (NA) and 5-hydroxytryptamine (5-HT) contribute to the occurrence of depression. Nevertheless, the therapy now accessible has limitations in terms of effectiveness and the accompanying negative consequences.&#xD;
Study Objectives:&#xD;
1.&#xD;
To evaluate the effects of Cilnidipine on depression paradigm in Male Swiss Mice using the Forced Swim Test, Tail Suspension Test and Locomotor Activity Test.&#xD;
2.&#xD;
To compare the effects of Cilnidipine and Fluoxetine on depression paradigm in Male Swiss Mice using the Forced Swim Test, Tail Suspension Test and Locomotor Activity Test.</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://localhost:8080/xmlui/handle/123456789/1874">
    <title>Effect Of Withania Somnifera On Selected Gene Expression In Brain Tissue Of Male Wistar Rats Subjected To Chronic Stress Induced Depression</title>
    <link>http://localhost:8080/xmlui/handle/123456789/1874</link>
    <description>Title: Effect Of Withania Somnifera On Selected Gene Expression In Brain Tissue Of Male Wistar Rats Subjected To Chronic Stress Induced Depression
Authors: REG.N0: BO0121002
Abstract: Introduction and Objective :-&#xD;
The present study was designed to evaluate the effect of Withania somnifera (WS) alone and in combination with Fluoxetine on gene expression of Neuritin, NARP &amp; BDNF Exon – III gene in hippocampus of male Wistar rats using chronic unpredictable mild stress (CUMS) as a model of depression.</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://localhost:8080/xmlui/handle/123456789/1873">
    <title>Investigation of Cardioprotective Potential of Remogliflozin in preventing Streptozotocin induced Diabetic Cardiomyopathy in Male Wistar Rats</title>
    <link>http://localhost:8080/xmlui/handle/123456789/1873</link>
    <description>Title: Investigation of Cardioprotective Potential of Remogliflozin in preventing Streptozotocin induced Diabetic Cardiomyopathy in Male Wistar Rats
Authors: REG.N0: BO0121001
Abstract: Introduction and objective - One of the cardiac problems that diabetes patients face is Diabetic&#xD;
Cardiomyopathy (DCM), which can lead to heart failure and an increase in morbidity and death. The&#xD;
two main pathogenic characteristics of diabetic hearts that contribute to the development of DCM are&#xD;
inflammation and oxidative stress. Because of its anti-oxidant and anti-inflammatory qualities,&#xD;
remogliflozin, an SGLT 2 inhibitor, has been demonstrated to lessen inflammation and oxidative&#xD;
stress. The purpose of this study was to look at how Remogliflozin protects diabetic hearts and assess&#xD;
via the corresponding changes in blood marker and histological characteristics.</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

